Molecular pathogenesis of sporadic prion diseases in man

Prion

Volumn 6, Issue 2, 2012, Pages 108-115

  Safar, Jiri G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Conformation of human prion protein; Diagnosis; Human prion strains; Neurodegeneration; Neuropathologic classification; Sporadic Creutzfeldt Jakob disease (sCJD)

Indexed keywords

PRION PROTEIN;

CONFERENCE PAPER; CONFORMATION DEPENDENT IMMUNOASSAY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DRUG EFFICACY; FUNGUS; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; IMMUNOASSAY; INSOMNIA; KURU; MOLECULAR PATHOLOGY; NONHUMAN; PHENOTYPE; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; SPORADIC FATAL INSOMNIA; VARIABLE PROTEASE SENSITIVE PRIONOPATHY; YEAST;

HUMANS; PHENOTYPE; PRION DISEASES; PRIONS;

MAMMALIAN PRION;

EID: 84861747139     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.18666     Document Type: Conference Paper

References (110)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science. 6801762.
2. Gajdusek DC. Slow-virus infections of the nervous system. N Engl J Med 1967; 276:392-400; PMID:6066787; http://dx.doi.org/10.1056/NEJM196702162760708.
3. Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 1994; 91:2839-42; PMID:7908444; http://dx.doi.org/10.1073/pnas.91.7.2839.
4. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224-33; PMID:10443888; http://dx.doi.org/10.1002/1531-8249(199908)46:2〈224::AIDANA12〉3.0. CO;2-W.
5. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003; 66:213-39; PMID:14522861; http://dx.doi.org/10.1093/bmb/66.1.213.
6. Prusiner SB, Ed. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 2004.
7. Holman RC, Belay ED, Christensen KY, Maddox RA, Minino AM, Folkema AM, et al. Human prion diseases in the United States. PLoS One 2010; 5:8521; PMID:20049325; http://dx.doi.org/10.1371/journal.pone.0008521.
8. Masters CL, Gajdusek DC, Gibbs CJ Jr, Bernouilli C, Asher DM. Familial Creutzfeldt-Jakob disease and other familial dementias: an inquiry into possible models of virus-induced familial diseases. In: Prusiner SB, Hadlow WJ, Eds. Slow Transmissible Diseases of the Nervous System. New York: Academic Press 1979; 1:143-94.
9. Jakob A. Über eine der multiplen Sklerose klinisch nahestehende Erkrankung des Zentralnervensystems (spastische Pseudosklerose) mit bemerkenswertem anatomischem Befunde. Mitteilung eines vierten Falles. Med Klin (Munich) 1921; 17:372-6.
10. Creutzfeldt HG. Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Gesamte Neurol Psychiatr 1920; 57:1-18; http://dx.doi.org/10.1007/BF02866081.
11. Masters CL, Gajdusek DC. The spectrum of Creutzfeldt-Jakob disease and virus-induced subacute spongiform encephalopathies. Recent Adv Neuropathol 1982; 2:139-63.
12. Wilson SAK. Syndrome of Jakob: Cortico-striatospinal degeneration. London: Edward Arnold 1940.
13. Kirschbaum WR. Jakob-Creutzfeldt Disease. Amsterdam: Elsevier 1968.
14. Nevin S, McMenemey WH, Behrman S, Jones DP. Subacute spongiform encephalopathy - a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 1960; 83:519-64; PMID:13728615; http://dx.doi.org/10.1093/brain/83.4.519.
15. Gambetti P, Parchi P. Insomnia in prion diseases: sporadic and familial. N Engl J Med 1999; 340:1675-7; PMID:10341282; http://dx.doi.org/10.1056/ NEJM199905273402111.
16. Mastrianni J, Nixon F, Layzer R, DeArmond SJ, Prusiner SB. Fatal sporadic insomnia: fatal familial insomnia phenotype without a mutation of the prion protein gene. Neurology 1997; 48:296.
17. Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008; 63:697-708; PMID:18571782; http://dx.doi.org/10.1002/ana.21420.
18. Gajdusek DC, Zigas V. Kuru; clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the eastern Highlands of New Guinea. Am J Med 1959; 26:442-69; PMID:13626997; http://dx.doi.org/10.1016/0002-9343(59)90251-7.
19. Gajdusek DC, Zigas V. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N Engl J Med 1957; 257:974-8; PMID:13483871; http://dx.doi.org/10.1056/ NEJM195711142572005.
20. Gajdusek DC. Kuru. Trans R Soc Trop Med Hyg 1963; 57:151-69; PMID:13946176; http://dx.doi.org/10.1016/0035-9203(63)90057-9.
21. Hadlow WJ. Scrapie and kuru. Lancet 1959; 274:289-90; http://dx.doi.org/10.1016/S0140-6736(59)92081-1.
22. Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968; 161:388-9; PMID:5661299; http://dx.doi.org/10.1126/ science.161.3839.388.
23. Gajdusek DC, Gibbs CJ Jr, Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 1966; 209:794-6; PMID:5922150; http://dx.doi.org/10.1038/209794a0.
24. Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann- Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981; 104:559-88; PMID:6791762; http://dx.doi.org/10. 1093/brain/104.3.559.
25. Tateishi J, Brown P, Kitamoto T, Hoque ZM, Roos R, Wollman R, et al. First experimental transmission of fatal familial insomnia. Nature 1995; 376:434-5; PMID:7630420; http://dx.doi.org/10.1038/376434a0.
26. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde (spastische Pseudosklerose- Encephalomyelopathie mit disseminierten Degenerationsherden). Z Gesamte Neurol Psychiatr 1921; 64:147-228; http://dx.doi.org/10.1007/BF02870932.
27. Loftus B, Rogers M. Characterization of a prion protein (PrP) gene from rabbit; a species with apparent resistance to infection by prions. Gene 1997; 184:215-9; PMID:9031631; http://dx.doi.org/10.1016/S0378-1119(96)00598-7.
28. Klatzo I, Gajdusek DC, Zigas V. Pathology of Kuru. Lab Invest 1959; 8:799-847; PMID:13665963.
29. Gibbs CJ Jr, Gajdusek DC. Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science 1973; 182:67-8; PMID:4199733; http://dx.doi.org/10.1126/science.182.4107.67.
30. Lampert PW, Gajdusek DC, Gibbs CJ Jr. Experimental spongiform encephalopathy (Creutzfeldt-Jakob disease) in chimpanzees. Electron microscopic studies. J Neuropathol Exp Neurol 1971; 30:20-32; PMID:4925307; http://dx.doi.org/10.1097/00005072-197101000-00004.
31. Beck E, Daniel PM, Matthews WB, Stevens DL, Alpers MP, Asher DM, et al. Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. Brain 1969; 92:699-716; PMID:4903507; http://dx.doi.org/10.1093/brain/92.4.699.
32. Sigurdsson B. Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br Vet J 1954; 110:341-54.
33. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, et al. Search for a prion-specific nucleic acid. J Virol 2005; 79:10796-806; PMID:16051871; http://dx.doi.org/10.1128/JVI.79.16.10796-806.2005.
34. Riesner D. The search for a nucleic acid component to scrapie infectivity. Semin Virol 1991; 2:215-26.
35. Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids and pathological membrane interactions. Annu Rev Biochem 2009; 78:177-204; PMID:19231987; http://dx.doi.org/10.1146/annurev.biochem.78. 082907.145410.
36. Cobb NJ, Surewicz WK. Prion diseases and their biochemical mechanisms. Biochemistry 2009; 48:2574-85; PMID:19239250; http://dx.doi.org/10.1021/ bi900108v.
37. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6; PMID:17991853; http://dx.doi.org/10. 1126/science.1138718.
38. Morales R, Abid K, Soto C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 2007; 1772:681-91.
39. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006; 313:1781-4; PMID:16990547; http://dx.doi.org/10. 1126/science.1131864.
40. Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009; 284:12845-52; PMID:19282288; http://dx.doi.org/10.1074/jbc.M808759200.
41. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 2009; 106:13010-5; PMID:19651612; http://dx.doi.org/10.1073/pnas.0903691106.
42. Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 2009; 106:20051-6; PMID:19892735.
43. Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 2010; 58:231-43; PMID:19672969; http://dx.doi.org/10.1002/glia.20919.
44. Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40:735-46; PMID:2859120; http://dx.doi.org/10.1016/0092-8674(85)90333-2.
45. Liao YC, Lebo RV, Clawson GA, Smuckler EA. Human prion protein cDNA: molecular cloning, chromosomal mapping and biological implications. Science 1986; 233:364-7; PMID:3014653; http://dx.doi.org/10.1126/science.3014653.
46. Baldwin MA, Stahl N, Burlingame AL, Prusiner SB. Structure determination of glycoinsotiol phospholipid anchors by permethylation and tandem mass spectrometry. Methods: A Companion to Methods in Enzymology 1990; 1:306-14.
47. Baldwin MA, Stahl N, Reinders LG, Gibson BW, Prusiner SB, Burlingame AL. Permethylation and tandem mass spectrometry of oligosaccharides having free hexosamine: analysis of the glycoinositol phospholipid anchor glycan from the scrapie prion protein. Anal Biochem 1990; 191:174-82; PMID:1981823; http://dx.doi.org/10.1016/0003-2697(90)90405-X.
48. Safar J, Ceroni M, Gajdusek DC, Gibbs CJ Jr. Differences in the membrane interaction of scrapie amyloid precursor proteins in normal and scrapie- or Creutzfeldt-Jakob disease-infected brains. J Infect Dis 1991; 163:488-94; PMID:1671680; http://dx.doi.org/10.1093/infdis/163.3.488.
49. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino A, et al. Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 1989; 274:1-13; PMID:2505674; http://dx.doi.org/10.1016/0003- 9861(89)90409-8.
50. Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 1990; 29:8879-84; PMID:1980209; http://dx.doi.org/10.1021/ bi00490a001.
51. Zahn R, Liu A, Lührs T, Riek R, von Schroetter C, López García F, et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 2000; 97:145-50; PMID:10618385; http://dx.doi.org/10.1073/ pnas.97.1.145.
52. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, et al. Conversion of alpha-helices into betasheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90:10962-6; PMID:7902575; http://dx.doi.org/10.1073/pnas.90.23.10962.
53. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. Conformational transitions, dissociation and unfolding of scrapie amyloid (prion) protein. J Biol Chem 1993; 268:20276-84; PMID:8104185.
54. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991; 30:7672-80; PMID:1678278; http://dx.doi.org/10.1021/bi00245a003.
55. Sc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. J Biol Chem 2009; 284:24233-41; PMID:19596861; http://dx.doi.org/10.1074/jbc.M109. 036558.
56. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65; PMID:9771749; http://dx.doi.org/10.1038/2654.
57. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868-75; PMID:12379130; http://dx.doi.org/10.1021/ bi025958g.
58. Nazor KE, Kuhn F, Seward T, Green M, Zwald D, Pürro M, et al. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J 2005; 24:2472-80; PMID:15962001; http://dx.doi.org/10.1038/sj.emboj.7600717.
59. Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439-77; PMID:18558863; http://dx.doi.org/10.1146/annurev. neuro.31.060407.125620.
60. Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772:629-44; PMID:17451912.
61. Milhavet O, Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 2002; 38:328-39; PMID:11890980; http://dx.doi.org/10.1016/S0165-0173(01)00150-3.
62. Prusiner SB. Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 2001; 344:1516-26; PMID:11357156; http://dx.doi.org/10.1056/ NEJM200105173442006.
63. Tremblay P, Ball HL, Kaneko K, Groth D, Hegde RS, Cohen FE, et al. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 2004; 78:2088-99; PMID:14747574; http://dx.doi.org/10.1128/JVI.78.4.2088- 99.2004.
64. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, et al. Prion clearance in bigenic mice. J Gen Virol 2005; 86:2913-23; PMID:16186247; http://dx.doi.org/10.1099/vir.0.80947-0.
65. Yuan J, Xiao X, McGeehan J, Dong Z, Cali I, Fujioka H, et al. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem 2006; 281:34848-58; PMID:16987816; http://dx.doi.org/10.1074/jbc.M602238200.
66. Linsell L, Cousens SN, Smith PG, Knight RS, Zeidler M, Stewart G, et al. A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering. Neurology 2004; 63:2077-83; PMID:15596753.
67. Cathala F, Baron H. Clinical aspects of Creutzfeldt- Jakob disease. In: Prusiner SB, McKinley MP, Eds. Prions - Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease. Orlando: Academic Press 1987; 467-509.
68. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20:597-602; PMID:3539001; http://dx.doi.org/10.1002/ana. 410200507.
69. Brown P, Cathala F, Sadowsky D, Gajdusek DC. Creutzfeldt-Jakob disease in France: II. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann Neurol 1979; 6:430-7; PMID:391141; http://dx.doi.org/10.1002/ana.410060510.
70. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859-68; PMID:7966576.
71. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079-82; PMID:8953038; http://dx.doi.org/10.1126/science.274.5295.2079.
72. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001; 10:854-63; PMID:11274476; http://dx.doi.org/10.1110/ps.39201.
73. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869-72; PMID:20044542; http://dx.doi.org/10.1126/science.1183218.
74. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, et al. Typing prion isoforms. Nature 1997; 386:232-4; PMID:9069279; http://dx.doi.org/10.1038/386232a0.
75. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383:685-90; PMID:8878476; http://dx.doi.org/10.1038/383685a0.
76. Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1999; 1:55-9; PMID:10559865; http://dx.doi.org/10.1038/9030.
77. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 2003; 278:40429-36; PMID:12917418; http://dx.doi.org/10.1074/jbc.M308550200.
78. Safar JG, Giles K, Lessard P, Letessier F, Patel S, Serban A, et al. Conserved properties of human and bovine prion strains on transmission to guinea pigs. Lab Invest 2011; 91:1326-36; PMID:21727894; http://dx.doi.org/10.1038/ labinvest.2011.89.
79. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389:448-50; PMID:9333232; http://dx.doi.org/10.1038/38925.
80. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767-78; PMID:8651649; http://dx.doi.org/10.1002/ana. 410390613.
81. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005; 102:3501-6; PMID:15741275; http://dx.doi.org/10.1073/pnas.0409651102.
82. Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A, et al. Beyond PrP9(res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 2008; 4:1000029; PMID:18389084; http://dx.doi.org/10.1371/journal. ppat.1000029.
83. Sc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 2005; 4:805-14; PMID:16297838; http://dx.doi.org/10.1016/S1474-4422(05)70225-8.
84. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 1999; 53:2173-6; PMID:10599800.
85. Kovács GG, Head MW, Hegyi I, Bunn TJ, Flicker H, Hainfellner JA, et al. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 2002; 12:1-11; PMID:11770893; http://dx.doi.org/10.1111/j.1750-3639.2002.tb00417.x.
86. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55:851-9; PMID:15174020; http://dx.doi.org/10.1002/ana.20127.
87. Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 2005; 65:113-8; PMID:16009895; http://dx.doi.org/10.1212/01. wnl.0000167188.65787.a0.
88. Scprofiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 2006; 3:14; PMID:16354106; http://dx.doi.org/10.1371/journal.pmed.0030014.
89. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009; 132:2643-58; PMID:19734292; http://dx.doi.org/10. 1093/brain/awp196.
90. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297-305; PMID:18684106; http://dx.doi.org/10.1042/BJ20081235.
91. Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002; 20:1147-50; PMID:12389035; http://dx.doi.org/10.1038/nbt748.
92. Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS, et al. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 2011; 7:1002242; PMID:21931554; http://dx.doi.org/10.1371/journal.ppat. 1002242.
93. Shirley BA, Ed. Protein Stability and Folding: Theory and Practice. Totowa, New Jersey: Humana Press 1995.
94. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 1994; 33:8375-83; PMID:8031772; http://dx.doi.org/10.1021/bi00193a027.
95. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987; 61:3688-93; PMID:2446004.
96. Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, Aguzzi A, et al. Prion protein expression in different species: analysis with a part of new mAbs. Proc Natl Acad Sci USA 1998; 95:8812-6; PMID:9671761; http://dx.doi.org/10.1073/pnas. 95.15.8812.
97. Choi EM, Geschwind MD, Deering C, Pomeroy K, Kuo A, Miller BL, et al. Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease. Lab Invest 2009; 89:624-35; PMID:19434060; http://dx.doi.org/10.1038/labinvest.2009.30.
98. Bellon A, Seyfert-Brandt W, Lang W, Baron H, Gröner A, Vey M. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol 2003; 84:1921-5; PMID:12810888; http://dx.doi.org/10.1099/vir.0.18996-0.
99. Thackray AM, Hopkins L, Bujdoso R. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Biochem J 2007; 401:475-83; PMID:17018021; http://dx.doi.org/10. 1042/BJ20061264.
100. Jones M, Peden AH, Yull H, Wight D, Bishop MT, Prowse CV, et al. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 2009; 49:376-84; PMID:18980616; http://dx.doi.org/10.1111/j.1537- 2995.2008.01954.x.
101. Pirisinu L, Di Bari M, Marcon S, Vaccari G, D'Agostino C, Fazzi P, et al. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS One 2010; 5:12723; PMID:20856860; http://dx.doi.org/10.1371/journal.pone.0012723.
102. Choi YP, Peden AH, Gröner A, Ironside JW, Head MW. Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol 2010; 84:12030-8; PMID:20844046; http://dx.doi.org/10.1128/JVI.01057-10.
103. Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 2010; 107:12005-10; PMID:20547859; http://dx.doi.org/10.1073/pnas.1004688107.
104. Sc fraction. Biochemistry 2006; 45:15710-7; PMID:17176093; http://dx.doi.org/10. 1021/bi0615442.
105. Notari S, Strammiello R, Capellari S, Giese A, Cescatti M, Grassi J, et al. Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J Biol Chem 2008; 283:30557-65; PMID:18753138; http://dx.doi.org/10.1074/jbc.M801877200.
106. Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, et al. Protease-sensitive synthetic prions. PLoS Pathog 2010; 6:1000736; PMID:20107515; http://dx.doi.org/10.1371/journal.ppat.1000736.
107. Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53:325-35; PMID:17270731; http://dx.doi.org/10.1016/j.neuron.2007.01.005.
108. Sc. J Pathol 2007; 213:21-6; PMID:17614097; http://dx.doi.org/10. 1002/path.2204.
109. Prusiner SB, Scott MR, DeArmond SJ, Carlson G. Transmission and replication of prions. In: Prusiner SB, Ed. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 2004; 187-242.
110. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585-9; PMID:16810177; http://dx.doi.org/10.1038/nature04922.